Smith LA - Search Results

1

Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset.

Jenner P, Zeng BY, Smith LA, Pearce RK, Tel B, Chancharme L, Moachon G. Jenner P, et al. Among authors: smith la. Exp Brain Res. 2000 Jul;133(2):178-88. doi: 10.1007/s002210000370. Exp Brain Res. 2000. PMID: 10968218

2

Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease.

Iczkiewicz J, Jackson MJ, Smith LA, Rose S, Jenner P. Iczkiewicz J, et al. Among authors: smith la. Brain Res. 2006 Nov 6;1118(1):239-50. doi: 10.1016/j.brainres.2006.08.036. Epub 2006 Sep 7. Brain Res. 2006. PMID: 16962083

3

Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset.

Smith LA, Jackson MG, Bonhomme C, Chezaubernard C, Pearce RK, Jenner P. Smith LA, et al. Clin Neuropharmacol. 2000 May-Jun;23(3):133-42. doi: 10.1097/00002826-200005000-00002. Clin Neuropharmacol. 2000. PMID: 10895396

4

Modafinil prevents the MPTP-induced increase in GABAA receptor binding in the internal globus pallidus of MPTP-treated common marmosets.

Zeng BY, Smith LA, Pearce RK, Tel B, Chancharme L, Moachon G, Jenner P. Zeng BY, et al. Among authors: smith la. Neurosci Lett. 2004 Jan 2;354(1):6-9. doi: 10.1016/j.neulet.2003.08.038. Neurosci Lett. 2004. PMID: 14698469

5

Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets.

Stockwell KA, Scheller DK, Smith LA, Rose S, Iravani MM, Jackson MJ, Jenner P. Stockwell KA, et al. Among authors: smith la. Exp Neurol. 2010 Jan;221(1):79-85. doi: 10.1016/j.expneurol.2009.10.004. Epub 2009 Oct 13. Exp Neurol. 2010. PMID: 19833125

6

Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.

Kuoppamäki M, Al-Barghouthy G, Jackson M, Smith L, Zeng BY, Quinn N, Jenner P. Kuoppamäki M, et al. Mov Disord. 2002 Nov;17(6):1312-7. doi: 10.1002/mds.10263. Mov Disord. 2002. PMID: 12465074

7

Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets.

Jackson MJ, Al-Barghouthy G, Pearce RK, Smith L, Hagan JJ, Jenner P. Jackson MJ, et al. Pharmacol Biochem Behav. 2004 Nov;79(3):391-400. doi: 10.1016/j.pbb.2004.07.015. Pharmacol Biochem Behav. 2004. PMID: 15582011

8

Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates.

Rose S, Scheller DK, Breidenbach A, Smith L, Jackson M, Stockwell K, Jenner P. Rose S, et al. Behav Pharmacol. 2007 Mar;18(2):155-60. doi: 10.1097/FBP.0b013e3280ebb400. Behav Pharmacol. 2007. PMID: 17351422

9

Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primates.

Hansard MJ, Smith LA, Jackson MJ, Cheetham SC, Jenner P. Hansard MJ, et al. Among authors: smith la. Eur J Pharmacol. 2002 Sep 13;451(2):157-60. doi: 10.1016/s0014-2999(02)02268-9. Eur J Pharmacol. 2002. PMID: 12231385

10

The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets.

Pearce RK, Smith LA, Jackson MJ, Banerji T, Scheel-Krüger J, Jenner P. Pearce RK, et al. Among authors: smith la. Mov Disord. 2002 Sep;17(5):877-86. doi: 10.1002/mds.10238. Mov Disord. 2002. PMID: 12360536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

747 results

Search Page

Filters